GoodRx Q4 revenue $184.1M beats guidance; Adjusted EBITDA margin 26.9% exceeds expectations

GoodRx Holdings, Inc.

2022-FY EPS reported -$0.08 revenue$766,554,000

Q4 revenue $184.1M, above guidance; net loss $2.01M (includes $29.4M stock-based comp).
Adjusted EBITDA $49.6M (26.9% margin), exceeding guidance; Adjusted Net Income $27.4M (14.9% margin).
Full year 2022 revenue $766.6M; Adjusted EBITDA $213.5M (27.8% margin).
Subscription offerings grew 42% YoY; over 7M consumers of prescription-related offerings.
Co-CEO cites strong subscription growth and efficiency improvements; 900K prescribers active.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

GoodRx Holdings, Inc. reported Full Year 2022 results: revenue $766.6 million, net income $32.8 1 million.

Period: Full Year 2022
Revenue: $766.6 million
Net income: $32.8 1 million
Result: reported results

Exact text from the filing

Full Year 2022 Highlights • Total revenue of $766.6 million • Net loss of $32.8 1 million; Net loss margin of 4.3%

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

GoodRx Holdings, Inc. reported Fourth Quarter 2022 results: revenue $184.1 million, net income $2.0 1 million.

Period: Fourth Quarter 2022
Revenue: $184.1 million
Net income: $2.0 1 million
Result: reported results

Exact text from the filing

Fourth Quarter 2022 Highlights • Total revenue of $184.1 million, exceeding previously announced guidance • Net loss of $2.0 1 million; Net loss margin of 1.1%

View on SEC.gov

Browse all earnings releases →

GoodRx Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-005068

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.